Smoking and Diabetic Nephropathy
In 1978, Christiansen reported that cigarette smoking is a risk factor for the development of diabetic nephropathy . He found a significantly higher prevalence of persistent proteinuria among patients who were or had been cigarette smokers. In a later study by Telmer et al. , the earlier findings were confirmed in a greater number and better characterised group of Type 1 diabetic patients. In 668 patients, the prevalence of diabetic nephropathy was significantly higher among heavy smokers (more than 10 cigarettes per day for more than 1 year) than among other patients, that is 19% vs. 12%. In addition, a higher frequency of clinical nephropathy was found with increasing cigarette consumption. Among patients who smoked a maximum of 10 cigarettes per day, about 13% had clinical diabetic nephropathy, whereas it was more than 25% among those patients who smoked 30 cigarettes per day. An association between smoking and nephropathy was also observed by Nordén and Nyberg . They compared smoking habits in 47 matched pairs of Type 1 diabetic patients with and without nephropathy. Patients with nephropathy had a significantly higher smoking index than their controls. There were also more current smokers, more heavy smokers, and fewer individuals who had never smoked in the nephropathy group than in the control group. With respect to retinopathy, study results had been controversial . It is of note, that in these early studies glycosylated haemoglobin values had not been included into the analyses as a possible confounding factor.
KeywordsDiabetic Patient Cigarette Smoking Diabetic Nephropathy Lupus Nephritis Nicotine Dependence
Unable to display preview. Download preview PDF.
- 7.Borch-Johnsen K, Nissen H, Henriksen E, Kreiner S, Sailing N, Deckert T, Nerup J. The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabetic Med 1987; 4: 201–210.Google Scholar
- 13.Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992; 152: 2082–2088.Google Scholar
- 14.Klein R, Klein BEK, Moss SE. Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 1993; 42: 381–389.Google Scholar
- 31.Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics) II: associated risk factors. Diabetologia 1990; 33: 542–548.PubMedCrossRefGoogle Scholar
- 41.Baumgartl H-J, Standi E, Vlassara H, Bucala R. Increase in serum ages (“advanced glycosylation end-products”) in IDDM patients who smoke (Abstract). Diabetologia 1996; 39: Suppl. 1: A291.Google Scholar
- 42.Fortmannn SP. Smoking: No time for complacency. Cardiovasc Risk Factors 1996; 6: 123–125.Google Scholar
- 43.Joossens L. Trends in uptake and quitting smoking in Europe. Cardiovasc Risk Factors 1996; 6: 126–129.Google Scholar
- 44.Kunze M. Epidemiology of nicotine dependence and general aspectss of smoking cessation. Cardiovasc Risk Factors 1996; 6: 130–134.Google Scholar
- 45.Fagerström KO, Säwe U. The pathophysiology of nicotine dependence: treatment options and the cardiovascular safety of nicotine. Cardiovasc Risk Factors 1996; 6: 135–143.Google Scholar
- 46.Wilhelmsen L. Benefits of quitting smoking for cardiac disease. Cardiovasc Risk Factors 1996; 6: 144–147.Google Scholar